These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26782531)

  • 21. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis.
    Fang SX; Chen C; Guo Q; Ke XX; Lu HL; Xu G
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 promotes lung adenocarcinoma by directly interacting with specificity protein 1.
    Li S; Ma F; Jiang K; Shan H; Shi M; Chen B
    Cancer Sci; 2018 May; 109(5):1346-1356. PubMed ID: 29575609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis.
    Pan J; Bian Y; Cao Z; Lei L; Pan J; Huang J; Cai X; Lan X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):329-335. PubMed ID: 31846184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis.
    Wei Y; Niu B
    Dis Markers; 2015; 2015():164635. PubMed ID: 26420912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
    Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
    J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
    Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
    Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long noncoding RNA MALAT1: a potential novel prognostic biomarkers in cancers based on Meta-analysis].
    Song W; Wang K; Zhang R; Zou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1163-1167. PubMed ID: 27932761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
    Huang C; Yu Z; Yang H; Lin Y
    Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
    Rong B; Nan Y; Liu H; Gao W
    Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
    Su Y; Chen H; Yao L; Dai H; Liu H
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):166-171. PubMed ID: 38279449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis.
    Tian X; Xu G
    BMJ Open; 2015 Sep; 5(9):e008653. PubMed ID: 26423854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
    Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
    Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma.
    Zhou J; Xiao H; Yang X; Tian H; Xu Z; Zhong Y; Ma L; Zhang W; Qiao G; Liang J
    Sci Rep; 2018 Jan; 8(1):37. PubMed ID: 29311567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.